2011
DOI: 10.1016/j.intimp.2011.01.031
|View full text |Cite
|
Sign up to set email alerts
|

Meeting report: Regulatory myeloid cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0

Year Published

2011
2011
2020
2020

Publication Types

Select...
4
1
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 10 publications
(10 reference statements)
0
4
0
Order By: Relevance
“…Unlike MDSCs, these immature myeloid cells are less suppressive (5). MDSCs quickly proliferate and migrate from the bone marrow in response to soluble mediators such as cytokines and chemokines that are produced at sites of inflammation and in the tumor milieu (6). …”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Unlike MDSCs, these immature myeloid cells are less suppressive (5). MDSCs quickly proliferate and migrate from the bone marrow in response to soluble mediators such as cytokines and chemokines that are produced at sites of inflammation and in the tumor milieu (6). …”
Section: Introductionmentioning
confidence: 99%
“…Granulocytic MDSCs (G-MDSCs) are polymorphonuclear and express high levels of Ly6G and low levels of Ly6C (68). G-MDSCs often utilize reactive oxygen species (ROS) and arginase 1 for their immunosuppressive function, and require antigen-specific interactions with their target T cells, although there is system-to-system variability (810).…”
Section: Introductionmentioning
confidence: 99%
“…Another immune regulatory cell type that has been well studied over the last decade is the myeloid-derived suppressor cell (MDSC) (reviewed in references [29][30][31][32]. Like CD4 ϩ FoxP3 ϩ Treg cells, MDSCs are viewed as primarily acting in a negative fashion with respect to protective T-cell immune responses, particularly in various tumor microenvironments.…”
mentioning
confidence: 99%
“…Recent studies report that MDSCs are involved in producing an immune regulatory cytokine environment that can present antigens to drive immature T cells to become noneffective in tumor clearance. 69,70 Thus, this study aimed to better elucidate the role of the pTyr vaccine in obstructing the tumor-promoting functions of MDSCs. The decrease in the MDSC population observed in tumors from pTyr-vaccinated mice, coupled with the observed decrease of IL-10, MCP-1, arginase II and CXCL5 ( Figure 5) in the tumor microenvironment, supports the hypothesis that the novel and enhanced pTyr vaccine is able to induce armed anti-Tyr effector CD8 + T cells to eliminate MDSCs.…”
Section: Discussionmentioning
confidence: 99%